LINC02535: A Long Intergenic Non-Protein-Coding RNA and a Potential Drug Target

Target Name: LINC02535

NCBI ID: G101928820

LINC02535

Other Name(s): Long intergenic non-protein coding RNA 2535, transcript variant 1 | long intergenic non-protein coding RNA 2535

LINC02535: A Long Intergenic Non-Protein-Coding RNA and a Potential Drug Target

LINC02535 is a long intergenic non-protein-coding RNA (lncRNA), which is typically not involved in protein coding. It was first identified in the human dataset using bioinformatics analysis and has been shown to have putative functions in various cellular processes, including cell adhesion, migration, and pluripotency. Additionally, LINC02535 has been shown to play a role in the development and progression of various diseases, such as cancer. Therefore, it is of great interest to investigate the potential drug targets associated with LINC02535.

Drug Targets associated with LINC02535

The identification of potential drug targets is an important step in the development of new treatments for various diseases. LINC02535 has been shown to play a role in the development and progression of various diseases, including cancer. Therefore, it is possible that LINC02535 may be a potential drug target.

One potential drug target associated with LINC02535 is the PI3K/Akt signaling pathway. The PI3K/Akt signaling pathway is a well-established signaling pathway that is involved in various cellular processes, including cell adhesion, migration, and angiogenesis. LINC02535 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which suggests that it may be a potential drug target.

Another potential drug target associated with LINC02535 is the NF-kappa signaling pathway. The NF-kappa signaling pathway is a signaling pathway that is involved in various cellular processes, including cell growth, differentiation, and inflammation. LINC02535 has been shown to be involved in the regulation of the NF-kappa signaling pathway, which suggests that it may be a potential drug target.

Conclusion

In conclusion, LINC02535 is a long intergenic non-protein-coding RNA that has been shown to play a role in various cellular processes and has been associated with the development and progression of various diseases, including cancer. Therefore, LINC02535 may be a potential drug target. Further research is needed to investigate the potential drug targets associated with LINC02535 and to develop new treatments for various diseases.

Protein Name: Long Intergenic Non-protein Coding RNA 2535

The "LINC02535 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02535 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets